Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310009, China
NCT Number: NCT04984642
The study plans to start in July 2021, and it is expected that 20 healthy people (aged 18-70 years old, BMI 18.5-40kg/m2) will carry out a 5-week intervention and follow-up. Participants will be enrolled in the group through the screening and plan to take regular diet, OGTT, high-fat diet, low-calorie diet and ketogenic diet within 5 weeks. The proteomics and metabolomics indicators of tear, plasma, and urine specimens will be measured at 5 time points at baseline, 30 minutes, 1 hour, 2 hours, and 3 hours for each diet. The correlation of proteomics and metabolomics indicators with classic laboratory parameters (BMI, HDL, LDL, cholesterol, triglyceride levels, and insulin resistance (HOMA-IR)) will be analyzed.
Looking for future studies?
Notify Me20 year–70 year
All sexes
Interventional
Not applicable
Hangzhou, Zhejiang, 310009, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
have OGTT,normal diet, high fat diet, low calorie diet, and ketogenic diet in turn
Time frame: 5 weeks
Changes of plasma, urine, tear proteomics and metabolomics after diet intervention
Second Affiliated Hospital, School of Medicine, Zhejiang University
Other
Plasma, Urine and Tear Omics Changes Based on Protein and Metabonomics Technology in Different Diets and Screening of Healthy Diet Markers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06550297
Blood Pressure, Cardiovascular Diseases
New York, United States
View Trial DetailsNCT05512247
Body Weight, Body Weight Changes
Birmingham, Alabama, United States
View Trial DetailsNCT06145009
Behavior, Behavior, Animal
Newark, Delaware, United States
View Trial DetailsNCT04725630
Diabetes Complications, Diabetes Mellitus
Various Cities, Alberta, Canada
View Trial Details